Results 241 to 250 of about 69,722 (292)

Increased HbA1c relative to actual glycemic control in patients treated with sodium–glucose cotransporter 2 inhibitors

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Aims/Introduction Among patients with diabetes receiving sodium–glucose cotransporter 2 (SGLT2) inhibitors, HbA1c levels are higher than glycated albumin levels. This study therefore aimed to evaluate the discrepancy between HbA1c and glucose management indicator (GMI), an index of glucose management derived from continuous glucose monitoring,
Keigo Mizutani   +14 more
wiley   +1 more source

Differential impact of COVID‐19 on change in body composition in young and older individuals with diabetes in the post‐COVID‐19 Era

open access: yesJournal of Diabetes Investigation, EarlyView.
This study reveals that lifestyle changes after COVID‐19 caused body composition changes in adults with diabetes, with effects persisting in older adults, especially males. It underscores the need for targeted interventions to mitigate long‐term health impacts in vulnerable populations. Abstract Aims/Introduction COVID‐19 containment measures in Japan,
Yuko Yamaguchi   +4 more
wiley   +1 more source

Efficacy of MiniMed™ 780G® on glucose management, sleep quality, and psychological aspects in persons with type 1 diabetes treated with MiniMed™ 770G®: A 3‐month prospective single‐center observational study

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Aims/Introduction The MiniMed™ 780G® is effective for improving glycemic control; however, few studies have specifically examined the impact of upgrading from MiniMed™ 770G® to MiniMed™ 780G® in adults. We determined the effects of upgrading from MiniMed™ 770G® to MiniMed™ 780G® (780G) on glucose management, psychological distress, daily life ...
Tomoaki Akiyama   +9 more
wiley   +1 more source

Efficacy and safety of SGLT2 inhibitor on insulin resistance and hyperglycemia in Werner syndrome—A case report

open access: yesJournal of Diabetes Investigation, EarlyView.
Dapagliflozin improved glycemic control and insulin resistance while preserving skeletal muscle mass, body weight, and renal function over 2 years in a patient with Werner syndrome. These findings suggest that SGLT2 inhibitors may be used safely with beneficial effects in patients with Werner syndrome.
Takashi Yagi   +7 more
wiley   +1 more source

Impact of glycemic variability on early detection of sudomotor dysfunction: Implications for early intervention and personalized treatment

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Background This study investigates the impact of glycemic variability on sudomotor dysfunction in type 2 diabetes mellitus. Methods A total of 206 type 2 diabetes mellitus patients and 34 healthy controls were included. Sweat function (SF) was assessed using electrochemical conductance of hands (HESC) and feet (FESC).
Yang Ou   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy